Hanseatic Management Services Inc Insulet Corp Transaction History

Hanseatic Management Services Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$225.52 - $304.06 $17,365 - $23,412	-77 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$215.97 - $265.89 $4,535 - $5,583	-21 Reduced 21.43%	77 $20,000
Q3 2020 Oct 29, 2020	SELL	$192.55 - $236.59 $612,501 - $752,592	-3,181 Reduced 97.01%	98 $23,000
Q1 2020 Apr 22, 2020	BUY	$130.01 - $216.44 $424,482 - $706,676	3,265 Added 23321.43%	3,279 $543,000
Q4 2019 Jan 29, 2020	BUY	$144.81 - $186.0 $2,027 - $2,604	14 New	14 $2,000

752

63.2M

467K

639K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.5B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.